Skip to main content
Livermore
Livermore
ZHEN

State Street Corp

SEC CIK
0000093751
Latest filing
Sep 22, 2026

TXMD holding history

TherapeuticsMD, Inc. in every 13F filed by State Street Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TXMD overviewAll 13F holders of TXMDFull Q2 2026 holdings

Shares (Q2 2026)
30,100
Value
$66.5K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of TXMD by State Street Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202630,100$66.5K<0.1%00.0%UnchangedHolders
Q1 202630,100$60.8K<0.1%00.0%UnchangedHolders
Q4 202530,100$49.1K<0.1%00.0%UnchangedHolders
Q3 202530,100$31.9K<0.1%00.0%UnchangedHolders
Q2 202530,100$34.9K<0.1%00.0%UnchangedHolders
Q1 202530,100$27.8K<0.1%00.0%UnchangedHolders
Q4 202430,100$25.9K<0.1%00.0%UnchangedHolders
Q3 202430,100$50.0K<0.1%00.0%UnchangedHolders
Q2 202430,100$48.5K<0.1%00.0%UnchangedHolders
Q1 202430,100$68.9K<0.1%00.0%UnchangedHolders
Q4 202330,100$67.7K<0.1%−28−0.1%ReducedHolders
Q3 202330,128$91.0K<0.1%00.0%UnchangedHolders
Q2 202330,128$124.1K<0.1%−20.0%ReducedHolders
Q1 202330,130$113.0K<0.1%+3,600+13.6%AddedHolders
Q4 202226,530$148.3K<0.1%+26,530NewHolders
Q3 20220$00.0%−30,462−100.0%Sold outHolders
Q2 202230,462$303.0K<0.1%−114,720−79.0%ReducedConverted for a 1-for-50 splitHolders
Q1 20227,259,095$2.76M<0.1%+19,452+0.3%AddedHolders
Q4 20217,239,643$2.57M<0.1%−405,965−5.3%ReducedHolders
Q3 20217,645,608$5.67M<0.1%−1,356,745−15.1%ReducedHolders
Q2 20219,002,353$10.7M<0.1%+1,818,736+25.3%AddedHolders
Q1 20217,183,617$9.63M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.